338 related articles for article (PubMed ID: 6407236)
1. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
Schröter G; Schrettenbrunner A; Strenzel I
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
[TBL] [Abstract][Full Text] [Related]
2. [Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
Le Noc P; Robert J; Le Noc D
Pathol Biol (Paris); 1984 May; 32(5):404-7. PubMed ID: 6429611
[TBL] [Abstract][Full Text] [Related]
3. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
Martino P; Venditti M; Valente B; Brandimarte C; Serra P
Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Braveny I; Machka K; Elsser R
Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
[TBL] [Abstract][Full Text] [Related]
6. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Corrado ML; Landesman SH; Cherubin CE
Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
[TBL] [Abstract][Full Text] [Related]
7. [Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains (author's transl)].
Grimm H
Arzneimittelforschung; 1982; 32(6):595-7. PubMed ID: 6214262
[TBL] [Abstract][Full Text] [Related]
8. [Activity of new beta-lactam antibiotics].
Cullmann W; Stieglitz M
Fortschr Med; 1982 May; 100(19):888-92. PubMed ID: 6807788
[TBL] [Abstract][Full Text] [Related]
9. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142
[TBL] [Abstract][Full Text] [Related]
10. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
Bartmann K; Tarbuc R
Infection; 1982; 10(6):361-70. PubMed ID: 6818153
[TBL] [Abstract][Full Text] [Related]
11. Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa.
Michael PR; Alford RH; McGee ZA
Antimicrob Agents Chemother; 1981 Nov; 20(5):702-4. PubMed ID: 6798926
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
Greenberg RN; Bollinger MR; Alivisatos MR
Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
[TBL] [Abstract][Full Text] [Related]
14. [In-vitro activity of new beta-lactam antibiotics. Testing resistant enterobacteria and pseudomonas aeruginosa strains].
Rosenthal E
Fortschr Med; 1984 Nov; 102(41):1051-2. PubMed ID: 6437952
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
[TBL] [Abstract][Full Text] [Related]
16. [In vitro comparative activity of 4 beta-lactams against Pseudomonas aeruginosa. Role of cefoperazone].
Joly-Guillou ML; Bergogne-Berezin E; Verin-Prevost C
Pathol Biol (Paris); 1984 May; 32(5):408-11. PubMed ID: 6429612
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Pusztai-Markos Z; Pranada F
Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
[TBL] [Abstract][Full Text] [Related]
18. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)].
Loch R; Schröter G
Zentralbl Bakteriol Orig A; 1979; 245(3):312-6. PubMed ID: 44785
[TBL] [Abstract][Full Text] [Related]
20. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
Chau PY; Ling J; Ng WS
J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
